Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
about
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@en
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@nl
type
label
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@en
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@nl
prefLabel
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@en
Intensive induction chemothera ...... gnosed acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Intensive induction chemothera ...... agnosed acute myeloid leukemia
@en
P2093
Alison R Sehgal
Anastasios Raptis
Jing Z Hou
Kathleen Dorritie
Michael Boyiadzis
Mounzer E Agha
Robert L Redner
Seah H Lim
P2860
P304
P356
10.1002/HON.2456
P577
2017-06-30T00:00:00Z